Delivery Order SPE2DB22D9112-SPE2DB25FTKPS
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, which is expected to be completed by September 3, 2025, covers the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare facilities. This award was issued without a set-aside designation, demonstrating the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on July 18, 2025. The delivery order, which must be completed by August 8, 2025, is for Stelara 90 mg/mL syringes and was issued without a set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $97,499.70 by the Defense Logistics Agency (DLA) on August 8, 2025. This firm fixed-price delivery order is for the supply of Stelara 90 mg/ml syringes, with an ultimate completion date of August 29, 2025. The contract utilizes no set-aside designation, demonstrating the company's competitive positioning in federal procurement markets. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $48,749.85 by the Defense Logistics Agency (DLA) on July 31, 2025. The delivery order, with an ultimate completion date of August 21, 2025, covers the supply of Stelara 90 mg/ml syringes—a prescription biologic medication used primarily for treating inflammatory conditions. This award carries no set-aside designation,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,499.90 on August 13, 2025, by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, which is scheduled for completion by September 4, 2025, represents a continuation of the company's substantial role as a critical supplier within the federal pharmaceutical supply chain. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency for Stelara 90 mg/mL syringes. The award is issued under a firm fixed-price contract type with an ultimate completion date of August 28, 2025. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Stelara 90 mg/mL syringes. The award represents a firm fixed-price delivery order with no set-aside designation, utilizing the company's existing Indefinite Delivery Contract with DLA under the SPE2DB program. The product will be delivered to Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for Stelara 90 mg/ml syringes with a ceiling value of $64,999.80. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499,999,999 and effective through November 2026. The award carries...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 12, 2025, for the supply of Stelara 90 mg/mL syringes under a firm fixed-price contract valued at $16,249.95. The order is set to be completed by September 3, 2025, with performance taking place at the contractor's facility in Park Ridge, Illinois. This delivery order was issued by the Medical Supply Chain, a defense-focused federal agency,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency for STELARA 90 MG/ML syringes. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a specific pharmaceutical procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award...
- SPE2DB22D9112Indefinite Delivery Contract
- SPE2DB22D9112-SPE2DB25FTKPSDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, which will be completed by September 3, 2025, covers the supply of Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. This award carries no set-aside designation and represents a direct transaction under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities. The delivery order exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, particularly for the Department of Defense healthcare system. The company has demonstrated consistent success in securing DLA contracts for specialized pharmaceutical products, including biologics and prescription medications essential to military medical operations. This award will be performed at the contractor's location in Park Ridge, Illinois, and reflects the company's ongoing capacity to deliver medical supplies and medications to federal healthcare facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.5k | 8/12/25 |